Back to search
FDAFDA · Food and drugs·Recall number D-1055-2014

Dicopanol FusePaq Kit for Oral Suspension, 5mg/ML

Published February 12, 2014 · Recall initiated: May 8, 2013

Summary

FDA records drug Class II recall D-1055-2014, published February 12, 2014 and initiated May 8, 2013. Recalling firm: Fusion Pharmaceuticals, LLC; Status: Terminated; Reported quantity: 1,200 kits; Lot: Lots: PL520, PL521, PL522 and PL523. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopanol FusePaq Kit due to Total Yeasts and Molds Count above USP limits.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fusion Pharmaceuticals, LLC
Distributor
CA
Lot
Lots: PL520, PL521, PL522 and PL523
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dicopanol FusePaq Kit for Oral Suspension, 5mg/ML recalled?

Yes. FDA published recall D-1055-2014 on February 12, 2014. Reported hazard: Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopanol FusePaq Kit due to Total Yeasts and Molds Count above USP limits.

What should I do if I have this product?

Voluntary: Firm initiated · Letter